Chapter 8: The Columbia Paperwork
I slid the first bound volume across the polished wood until it stopped directly in front of Harold Sterling.
"In August of 2022," I began, looking straight into the eyes of the board members, "Caldwell Enterprises established a restricted research grant at Columbia University worth three hundred thousand dollars. The grant was designated for the Department of Biochemistry to fund lipid nanoparticle delivery systems for targeted oncology drugs."
Sterling frowned, adjusting his reading glasses. "We fund dozens of university programs, Ms. Martinez. What does this have to do with the Haynes merger?"
"Because three weeks after that grant was established," I continued, "my primary research advisor at Columbia informed me that my fellowship had been fully funded by an anonymous donor. But attached to that funding was a non-disclosure agreement and a clause transferring the intellectual property rights of my lab work to a holding company called *Helios Innovation LLC*."
Richard Haynes’ smile froze. The color began to drain slowly from his ears.
"I didn't know who owned Helios Innovation back then," I said, taking a step toward the center of the table. "I was twenty-four, pregnant, terrified, and desperate to keep my healthcare. I signed the IP transfer because I thought it was standard university protocol."
I picked up the second volume and slammed it down in front of Richard Haynes.
"Yesterday afternoon, Mr. Vance's investigators pulled the corporate registration for Helios Innovation LLC from the Delaware state registry," I said, my voice ringing like a bell. "Helios is a shell company owned ninety percent by the Haynes Group, and ten percent by Dr. Gregory Vance—Richard Haynes' nephew and the chief science officer of Haynes Pharmaceutical."
The board members looked at each other, a sudden, sharp tension filling the room.
"Six months ago," I pressed on, "Haynes Pharmaceutical filed a utility patent for a 'novel lipid delivery vehicle.' The molecular structures, the specific pH-dependent ionization curve, and the core reaction steps listed in claims 1 through 14 of your patent are a word-for-word, structure-for-structure copy of my Columbia dissertation draft—research that was stolen using a Caldwell Foundation grant as cover."
"This is absurd!" Richard bellowed, standing up so fast his leather chair scraped violently against the floor. "She was a student! A lab assistant! She has no standing to claim IP ownership!"
"I don't just have standing, Mr. Haynes," I said, leaning over the table, staring him dead in the eye. "I have the original timestamped lab notebooks, the raw spectrographic data, and the digital signatures from the Columbia server. You didn't just steal my research. You used a Caldwell Enterprise charity vehicle to commit corporate espionage and patent fraud to float your upcoming pharmaceutical IPO."
---
